Prescot, Andrew P.
Prisciandaro, James J.
Miller, Steven R.
Ingenito, Gary
Kondo, Douglas G.
Renshaw, Perry F.
Funding for this research was provided by:
Catalyst Pharmaceuticals Inc
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K24 DA015116)
Article History
Received: 4 January 2018
Accepted: 22 August 2018
First Online: 4 September 2018
Competing Interests
: The authors declare no competing interests.